NEW YORK, Feb. 22, 2012  /PRNewswire/ --  Reportlinker.com announces that a new market research report is available in its catalogue:

Future US Tumor Marker Testing Market Outlook

http://www.reportlinker.com/p0774962/Future-US-Tumor-Marker-Testing-Market-Outlook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Complete report $8,700.  DataPack (test volumes, sales forecasts, supplier shares) $3,450.

Highlights

• Comprehensive 620-page analysis of the US tumor marker testing market.
• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
• Ten-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
• Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
• Current instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Contains 620 pages and 103 tables

Table of Contents Introduction

Worldwide Market and Technology Overview

A. Cancer Statistics and Etiology

1. Brest Cancer

2. Lung Cancer

3. Colon and Rectum Cancer

4. Prostate Cancer

5. Stomach Cancer

6. Leukemia

7. Lymphoma

8. Oral Cancer

9. Skin Cancer

10. Uterine Cancer

11. Ovarian Cancer

12. Bladder Cancer

B. Major Current And Emerging Cancer Diagnostic Tests

1. Introduction

2. Tumor Marker Classification

3. ACTH

4. Alpha-Fetoprotein (AFP)

5. Beta-2 Microglobulin

6. CA 15-3/27.29

7. CA 19-9

8. CA-125

9. Calcitonin

10. Carcinoembrionic Antigen (CEA)

11. Estrogen and Progesterone Receptors

12. Ferritin

13. Gastrin

14. Human Chorionic Gonadotropin (HCG)

15. Insulin

16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5'-Nucleotidase27. Oncogenes- Abl/abl-bcr- AIB1- BCL-2- BRCA1- CD44- C-fos- C-myb- C-myc- CYP-17- Erb-B- HPC1- N-myc- P40- P51- P53- PIK3CA- PTI-1- Ras- Reg- Sis- Src

28. Polypeptide Growth Factors

? Basic Fibroblast Growth Factor

- Beta-TGF

- Cachectin (TNT)

- Calmodulin

- ECFR

- Nerve Growth Factor (NGF)

- Epidermal Growth Factor (EGF)

- Ornithine Decarboxylase

- Transferrin

- Transforming Growth Factor-Alpha

29. Ectopic Hormones

30. Colony Stimulating Factors

31. Lymphokines

- Alpha-Interferon

- B Cell Growth Factors

- B Cell Growth Factor (BCGF)

- Gamma-Interferon

- Interleukin-1 (IL-1)

- Macrophage Activating Factor

32. Immunohistochemical Stains

33. Emerging Tumor Markers

- N-Acetylglucosamine

- Actin

- Alpha-Actin

- Antineuronal Antibodies

- 7B2

- B72.3

- Bax

- BCD-F9

- BLCA-4

- Blood Group Antigens A,B,H

- CA 50

- CA 72-4/TAG-72

- CA 195

- CA-242

- CA-549

- CAM 26

- CAR-3

- Cathepsin-D- Chromogranin A and B- Cluster 1 Antigen- Cluster-5/5A Antigen- CTA- CU18- DR-70- DU-PAN-2- Endometrial Bleeding Associated Factor- Endostatin- Epithelial Membrane Antigen- Feulgen Hydrolysis- Fibronectin- FSH- (1->3)-L-fucosyltransferase- Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Intermediate Filaments- Cytokeratins/CK18/Cyfra 21-1- Desmin- Gliofibrillary Acid Protein- Neurofilaments- Vimentin- KA 93- Kinases- KP16D3- LAI- Leukocyte Common Antigen- Lewis Antigens- Lysophosphatidic Acid (LPA)- Ma 695/Ma 552- MABDF3- MAG- ME1

- Minactivin

- MN/CA9

- MSA

- Mucin Cancer Antigen (MCA)

- Multiple Tumor Suppressor 1

- Myosin

- NEA-130

- NMP22

- OA-519

- Opiod Peptides

- P-glycoprotein

- Pancreatic Oncofetal Antigen (POA)

- Placental Lactogen

- PR92

- Proliferative Index, Ki-67

- Px

- RB Inactivation/Deletion

- Ret

- SCCL 175

- Selectin

- Sialic Acid

- Sialyl SSEA-1/SLX

- SN10

- Somatostatin

- TA-90

- TABA

- Tachykinin

- TAG 12

- TPS

- Troponin

- Tubulin

- VCAM

- VEGF

- Villen

C. Instrumentation Review And

Market Needs

1. Abbott AxSYM

2. Abbott Architect c4000

3. Abbott Architect i2000 Series

4. Abbott Architect ci8200 System

5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS213. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)- Overview- ELISA- Immunofiltration- Particle-Membrane Capture Immunoassay- Enzyme Amplification

d. Fluorescent Immunoassays

e. Luminescence

- Chemiluminescence

- Bioluminescence

f. Latex Agglutination

g. Immunoprecipitation

H. Affinity Chromatographu

e. Liposome Flow-Injection Immunoassay

3. Molecular Diagnostics

a. Technology Overview

b. Amplification Methods

- PCR

- DAP-PCR

- Immuno-PCR

- QC-PCR

- CAR

- DNA

- HPA

- LCR

- NASBA

- QBR

- SDA

- 3 SR, and others

4. Chromosome Analysis

a. Chronic Myelogenous Leukemia (CML)

b. Acute Myeloid Leukemia (AML)

c. Acute Lymphoblastic Leukemia (ALL)

d. Malignant Lymphomas

Lymphoid Malignancies

e. Chronic Lymphocytic Leukemia (CLL)

f. Solid Cancers

g. Chromosomal Translocation and Oncogenes

5. Artificial Intelligence

6. Flow Cytometry

7. Two Dimensional Gel Electrophoresis (2-DGE)

8. Biosensors

9. Competing/Complementing Technologies

a. CT

b. MRI

c. NMRd. PETe. Photonics SpectroscopyE. Personal TestingU.S.A.A. Executive SummaryB. Business Environment1. Health Care Expenditures2. Cost Consciousness3. Industry Consolidation4. Managed Care5. Hospitals6. Admissions7. Length of Stay8. Industry Diversification9. Physician Demographics10. Population Aginga. Chronic Illnessb. Disease Incidencec. Susceptibility to Iatrogenesisd. Multiple Illness Cases11. Laboratory RegulationsC. Market Structure1. Centralized Testinga. Hospitalsb. Commercial/Private Laboratories2. POT/Decentralized Testinga. Physician Offices/Group Practicesb. Cancer Clinicsc. Point-Of-Care Testingd. Other Decentralized Testing LocationsD. Market Size, Growth and Major Suppliers Sales,Instrument Placements and Market Shares

Major Product Development Opportunities

A. Reagent Kits and Test Systems/Panels

B. Instrumentation

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation Factor

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Profiles

- Abbott

- AdnaGen

- Applied Gene Technologies

- Arca- Beckman Coulter/Danaher- Becton Dickinson- Biomedical Diagnostics- bioMerieux- Bio-Rad- Cepheid- Correlogic Systems- Dako- Decode- Diadexus- Diagnocure- Diasorin- Eiken Chemical- Enterix- Enzo Biochem- Epigenomics- Exact Sciences- Fujirebio- Gen-Probe- Guided Therapeutics- Hologic- Ipsogen- Kreatech- Kyowa Medex- Life Technologies- Mackay Life Sciences- Myriad Genetics- Nanogen Elitech- OncoLab- Otho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco- PreMD- Qiagen- Radient Pharmaceuticals- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac/PE

- Zila

Appendixes Appendix I: Major Universities and Research

Centers Developing Cancer Diagnostic

Technology and Applications

Appendix II: Assumed Currency Exchange Rates

List of Tables Tumor Marker Classification

Major Companies Developing or Marketing

ACTH Tests

Major Companies Developing or Marketing

AFP Tests

Major Companies Developing or Marketing

Beta-2 Microglobulin Tests

Major Companies Developing or Marketing

CA 15-3/27.29 Tests

Major Companies Developing or Marketing

CA 19-9 Tests

Major Companies Developing or Marketing

CA 125 Tests

Major Companies Developing or Marketing

Calcitonin Tests

Major Companies Developing or Marketing

CEA Tests

Major Companies Developing or Marketing

Estrogen Receptor Tests

Major Companies Developing or Marketing

Progesterone Receptor Tests

Major Companies Developing or Marketing

Ferritin Tests

Major Companies Developing or Marketing

Gastrin Tests

Major Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingInsulin TestsMajor Companies Developing or MarketingNSE TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingPAP Smear/HPV TestsMajor Companies Developing or MarketingPAP TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingLymphocyte Subclassification TestsBiochemical Markers Potential ApplicationsIn Cancer DiagnosisOncogenes Potential ApplicationsIn Cancer DiagnosisMajor Companies Developing or MarketingOncogene TestsGrowth Factors Potential ApplicationsIn Cancer DiagnosisColony Stimulating Factors PotentialApplications in Cancer DiagnosisLymphokines Potential ApplicationsIn Cancer Diagnosis

Immunohistochemical Stains Potential

Applications in Cancer Diagnosis

Executive Summary Table: U.S., Total Tumor

Marker Test Volume and Sales Forecast by

Market Segment

U.S., Estimated New Cancer Cases and Deaths

U.S., Estimated Cancer Death Rates

Per 100,000 Population

U.S., Laboratories Performing Tumor

Marker Tests by Market Segment

U.S., Hospital Laboratories Performing

Tumor Marker Tests by Bed Size

U.S., Commercial/Private Laboratories

Performing Tumor Marker Tests by

Annual Test Volume

U.S., Physician Office Laboratories

Performing Tumor Marker Tests by

Practice Size

U.S., Total Tumor Marker Test Volume

Forecast by Market Segment-201

U.S., All Market Segments Major

Tumor Marker Test Volume Forecast

U.S., Hospital Laboratories Major Tumor

Marker Test Volume Forecast by Test

U.S., Commercial/Private Laboratories

Major Tumor Marker Test Volume

Forecast

U.S., Physician Offices/Group PracticesMajor Tumor Marker Test VolumeForecastU.S., Cancer Clinics Major TumorMarker Test Volume Forecast by TestU.S., Total Tumor Marker SalesForecast by Market SegmentU.S., All Market Segment Major TumorMarker Sales Forecast by TestU.S., Hospital Laboratories Major TumorMarker Sales Forecast by TestU.S., Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast byTestU.S., Physician Offices/Group PracticesMajor Tumor Marker Sales Forecast byTestU.S., Cancer Clinics Major TumorMarker Sales Forecast by TestU.S., ACTH Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., AFP Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Beta-2 Microglobulin Test VolumeAnd Diagnostics Sales Forecast by MarketSegment

U.S., CA 15-3/27.29 Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., CA 19-9 Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., CA-125 Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Calcitonin Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., Cathepsin Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., CEA Test Volume and Diagnostics

Sales by Market Segment

U.S., Chromogranin Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., Colon-specific Antigen Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., Cytokeratins Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., Estrogen Receptor Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., Ferritin Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., HCG Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Interferons Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Interleukins Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., NSE Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Nucleolar Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentU.S., Oncogenes Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market Segment

U.S., PAP Smear Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Parathyroid Hormone

Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Progesterone Receptor

Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., PAP Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., PSA Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., S-100 Protein Test Volume and

Diagnostics Sales Forecast by Market

Segment

U.S., Serotonin Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Sialic Acid Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Squamous Cell Carcinoma Antigen

Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., TDT Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Thymidine Kinase

Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S., Thyroglobulin TestVolume and DiagnosticsSales Forecast by Market SegmentU.S., TPA Test Volume and DiagnosticsSales Forecast by Market SegmentU.S., Total Tumor Marker SalesBy Major SupplierU.S., ACTH Testing Market DiagnosticsSales by Major SupplierU.S., AFP Testing Market DiagnosticsSales by Major SupplierU.S., Beta-2 Migroblolulin Testing MarketDiagnostics Sales by Major SupplierU.S., CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierU.S., CA 19-9 Testing Market DiagnosticsSales by Major SupplierU.S., CA 125 Testing Market DiagnosticsSales by Major SupplierU.S., CEA Testing Market DiagnosticsSales by Major SupplierU.S., Ferritin Testing MarketDiagnostics Sales by Major SupplierU.S., HCG Testing MarketDiagnostics Sales by Major SupplierU.S., Insulin Testing MarketDiagnostics Sales by Major SupplierU.S., Parathyroid Hormone TestingMarket Diagnostics Sales by Major SupplierU.S., PAP Testing Market DiagnosticsSales by Major SupplierU.S., Progesterone Receptor Testing MarketDiagnostics Sales by Major SupplierU.S., PSA Testing Market DiagnosticsSales by Major Supplier

To order this report:In Vitro Diagnostic Industry: Future US Tumor Marker Testing Market Outlook

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com